Cancer Publications 2013

26 Jan 2023
26 Jan 2023
  1. Abdullah, Y., Karpelowsky, J., Davidson, A., Thomas, J., Brooks, A., Hewitson, J., Numanoglu, A., Cox, S. et al. 2013. Management of nine cases of Wilms’ tumour with intracardiac extension—a single centre experience. Journal of Pediatric Surgery. 48(2): 394-399.
  2. Adefuye, P.O., Broutet, N.J., de Sanjosé, S. & Denny, L.A. 2013. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Vaccine. 31F53-F59.
  3. Adler, D.H., Laher, F., Lazarus, E., Grzesik, K., Gray, G.E., Allan, B. & Williamson, A., 2013. A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents. Journal of Immunological Techniques in Infectious Diseases, 02(03).
  4. Aliwaini, S., Swarts, A.J., Blanckenberg, A., Mapolie, S. & Prince, S. 2013. A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo mthrough apoptosis and autophagy. Biochemical Pharmacology. 86(12): 1650-1663.
  5. Alleyne-Mike, K., van Wijk, L. & Hunter, A. 2013. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23(7): 1287-1294. DOI:10.1097/IGC.0b013e31829fb834 [doi].
  6. Awolude, O.A., Morhason-Bello, I.O., Denny, L.A. & Adewole, I.F. 2013. Human Papillomavirus Infection and Related Cancers in Sub-Saharan Africa: Burden and Tools for Prevention. Vaccine. 31vii-x.
  7. Baigrie, R.J. 2013. Modern management of colorectal cancer: review article. South African Family Practice. 55(1): 47-52.
  8. Berger, H., Vegran, F., Chikh, M., Gilardi, F., Ladoire, S., Bugaut, H., Mignot, G., Chalmin, F. et al. 2013. SOCS3 transactivation by PPARgamma prevents IL-17-driven cancer growth. Cancer Research. 73(12): 3578-3590. DOI:10.1158/0008-5472.CAN-12-4018 [doi].
  9. Bloom, C.I., Graham, C.M., Berry, M.P., Rozakeas, F., Redford, P.S., Wang, Y., Xu, Z., Wilkinson, K.A. et al. 2013. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PloS One. 8(8): e70630.
  10. Bosch, F.X., Broker, T.R., Forman, D., Moscicki, A., Gillison, M.L., Doorbar, J., Stern, P.L., Stanley, M. et al. 2013. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31H1-H31.
  11. Bruwer, Z., Futter, M. & Ramesar, R. 2013. A mobile colonoscopic unit for lynch syndrome: trends in surveillance uptake and patient experiences of screening in a developing country. Journal of Genetic Counseling. 22(1): 125-137.
  12. Cairncross, L. & Panieri, E. 2013. Pre-operative diagnosis of thyroid cancer: Clinical, radiological and pathological correlation. South African Journal of Surgery. 51(2): 46-49.
  13. Chetty, R. & Govender, D. 2013. Gene of the month: KRAS. Journal of Clinical Pathology. 66(7): 548-550. DOI:10.1136/jclinpath-2013-201663 [doi].
  14. Chiririwa, H., Moss, J.R., Hendricks, D., Meijboom, R. & Muller, A. 2013. Synthesis, characterisation and in vitro evaluation of palladium (II) iminophosphine complexes for anticancer activity. Transition Metal Chemistry. 38(2): 165-172.
  15. Coetzee, E.D. & Thomson, S.R. 2013. Inherited colorectal cancer: A plea for a national registry. South African Journal of Surgery. 51(2): 42-43.
  16. Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., Huot, L., Grandjean, T. et al. 2013. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. The Journal of Clinical Investigation. 123(2): 700-711.
  17. Davidson, A. & Hendricks, M. 2013. Experience with B-cell lymphoma at a South African centre in the HIV Era. Transfusion and Apheresis Science. 49(1): 31-39.
  18. De Vuyst, H., Alemany, L., Lacey, C., Chibwesha, C.J., Sahasrabuddhe, V., Banura, C., Denny, L. & Parham, G.P. 2013. The burden of human papillomavirus infections and related diseases in sub-Saharan Africa. Vaccine. 31F32-F46.
  19. Denny, L., Hendricks, B., Gordon, C., Thomas, F., Hezareh, M., Dobbelaere, K., Durand, C., Hervé, C. et al. 2013. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study. Vaccine. 31(48): 5745-5753.
  20. Denny, L.A., Sankaranarayanan, R., De Vuyst, H., Kim, J.J., Adefuye, P.O., Alemany, L., Adewole, I.F., Awolude, O.A. et al. 2013. Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 31 Suppl 5F73-4.
  21. Duarte, J., Serufuri, J., Mulder, N. & Blackburn, J. 2013. Protein function microarrays: design, use and bioinformatic analysis in cancer biomarker discovery and quantitation. In Bioinformatics of Human Proteomics. Springer. 39-74.
  22. Edkins, O., Hofmeyr, C. & Fagan, J. 2013. Does sentinel lymph node biopsy have a role in node-positive head and neck squamous carcinoma? South African Journal of Surgery. 51(1): 22-25.
  23. Fagan, J.J., Lentin, R. & Quail, G. 2013. International practice of laryngectomy rehabilitation interventions: a perspective from South Africa. Current Opinion in Otolaryngology & Head and Neck Surgery. 21(3): 199-204. DOI:10.1097/MOO.0b013e328360c3c1 [doi].
  24. Fenner, L., Reid, S.E., Fox, M.P., Garone, D., Wellington, M., Prozesky, H., Zwahlen, M., Schomaker, M. et al. 2013. Tuberculosis and the risk of opportunistic infections and cancers in HIV‐infected patients starting ART in Southern Africa. Tropical Medicine & International Health. 18(2): 194-198.
  25. Firnhaber, C., Mayisela, N., Mao, L., Williams, S., Swarts, A., Faesen, M., Levin, S., Michelow, P. et al. 2013. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PloS One. 8(1): e53494.
  26. Gichuhi, S. & Irlam, J.H. 2013. Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals. Cochrane Database Syst.Rev. 18.
  27. Gompel, A., Baber, R., de Villiers, T., Huang, K., Santen, R., Shah, D., Villaseca, P. & Shapiro, S. 2013. Oncology in midlife and beyond. Climacteric. 16(5): 522-535.
  28. Harding, R., Selman, L., Powell, R.A., Namisango, E., Downing, J., Merriman, A., Ali, Z., Gikaara, N. et al. 2013. Research into palliative care in sub-Saharan Africa. The Lancet Oncology. 14(4)
  29. Haus, N.J., Kambarami, T. & Dyer, R. 2013. Spinal anaesthesia for brachytherapy for carcinoma of the cervix: a comparison of two dose regimens of hyperbaric bupivacaine. Southern African Journal of Anaesthesia and Analgesia. 19(3): 154-159.
  30. Israels, T., Renner, L., Hendricks, M., Hesseling, P., Howard, S. & Molyneux, E. 2013. SIOP PODC: Recommendations for supportive care of children with cancer in a low‐income setting. Pediatric Blood & Cancer. 60(6): 899-904.
  31. Kew, M. 2013. Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update. Journal of Viral Hepatitis. 20(3): 149-157.
  32. Kew, M.C. 2013. Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointestin Liver Dis. 22(3): 305-310.
  33. Kew, M.C. 2013. Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol. 12173-182.
  34. Kingham, T.P., Alatise, O.I., Vanderpuye, V., Casper, C., Abantanga, F.A., Kamara, T.B., Olopade, O.I., Habeebu, M. et al. 2013. Treatment of cancer in sub-Saharan Africa. The Lancet Oncology. 14(4): e158-e167.
  35. Krige, J., Bernon, M., & Beningfield, S., 2013. Modern management of colorectal liver metastases. Continuing Medical Education, 31(6), 197-200.
  36. Li, J., Weinberg, M.S., Zerbini, L. & Prince, S. 2013. The oncogenic TBX3 is a downstream target and mediator of the TGF-beta1 signaling pathway. Molecular Biology of the Cell. 24(22): 3569-3576. DOI:10.1091/mbc.E13-05-0273 [doi].
  37. Lombard, M., Steyn, N., Burger, H., Charlton, K. & Senekal, M. 2013. A food photograph series for identifying portion sizes of culturally specific dishes in rural areas with high incidence of oesophageal cancer. Nutrients. 5(8): 3118-3130.
  38. Maskew, M., Fox, M.P., van Cutsem, G., Chu, K., MacPhail, P., Boulle, A. & Egger, M. 2013. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study. PloS One. 8(6): e64392.
  39. Matheson, G.O., Klugl, M., Engebretsen, L., Bendiksen, F., Blair, S.N., Borjesson, M., Budgett, R., Derman, W. et al. 2013. Prevention and management of non-communicable disease: the IOC consensus statement, Lausanne 2013. British Journal of Sports Medicine. 47(16): 1003-1011.
  40. Molla, M.R., Ferdousi, F. & Khaled, A. 2014. Melanotic Neuroectodermal Tumor of Infancy. Pulse. 5(1): 61-65.
  41. Molyneux, E., Davidson, A., Orem, J., Hesseling, P., Balagadde‐Kambugu, J., Githanga, J. & Israels, T. 2013. The management of children with Kaposi sarcoma in resource limited settings. Pediatric Blood & Cancer. 60(4): 538-542.
  42. Moodley, I., Tathiah, N., Mubaiwa, V. & Denny, L. 2013. High uptake of Gardasil vaccine among 9-12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. SAMJ: South African Medical Journal. 103(5): 313-317.
  43. Morhason-Bello, I.O., Odedina, F., Rebbeck, T.R., Harford, J., Dangou, J., Denny, L. & Adewole, I.F. 2013. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. The Lancet Oncology. 14(4): e142-e151.
  44. Mueck, A.O. 2013. Does hormone replacement therapy (HRT) cause breast cancer? An application of causal principles to three studies Part 5. Trends in breast cancer incidence in relation to the use of HRT. Journal of Family Planning & Reproductive Health. 39: 80-88.
  45. Pather, S., Mohamed, Z., McLeod, H. & Pillay, K. 2013. Large Cell Lymphoma: Correlation of HIV Status and Prognosis with Differentiation Profiles Assessed by Immunophenotyping. Pathology & Oncology Research. 19(4): 695-705.
  46. Peres, J. & Prince, S. 2013. The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion. Molecular Cancer. 12(1): 117-4598-12-117. DOI:10.1186/1476-4598-12-117 [doi]. .
  47. Pillay, K., Hendricks, M. & Davidson, A. 2013. HHV-8 large T-cell lymphoma: an unusual malignancy amidst more common B-cell lymphomas in HIV-positive children treated at a single institution. Journal of Pediatric hematology/oncology. 35(6): e246-8. DOI:10.1097
  48. Roberts, L.J., Hardie, S., Hoosen, T.G., Ramesar, R. & Greenberg, L.J. 2013. The value of genetic testing for inherited retinal disease caused by mutations in the ABCA4 gene in South Africans. SAMJ: South African Medical Journal. 103(10): 702-703.
  49. Sankaranarayanan, R., Anorlu, R., Sangwa-Lugoma, G. & Denny, L.A. 2013. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa. Vaccine. 31F47-F52.
  50. Sauer, J., Simonds, H., Van der Merwe, H. & Hattingh, R. 2013. A retrospective analysis comparing clinical staging with magnetic resonance imaging staging in patients with cervical cancer. Southern African Journal of Gynaecological Oncology. 5(1): 11-15.
  51. Stannard, C., Vernimmen, F., Carrara, H., Jones, D., Fredericks, S., Hille, J. & de Kock, E. 2013. Malignant salivary gland tumours: Can fast neutron therapy results point the way to carbon ion therapy? Radiotherapy and Oncology. 109(2): 262-268.
  52. Smit BJ, van Wijk AL., 2013. An improved, disposable indwelling intrauterine tube ("smit sleeve") not requiring retaining stitches for brachy-radiotherapy for carcinoma of the cervix. European Journal of Gynaecological Oncology, 34(4):289-90.
  53. Stephenson, K., Peer, S., Govender, D. & Fagan, J. 2013. Plasmablastic lymphoma of the larynx: report of two cases. The Journal of Laryngology & Otology. 127(01): 96-99.
  54. Sunassee, S.N., Veale, C.G., Shunmoogam-Gounden, N., Osoniyi, O., Hendricks, D.T., Caira, M.R., de la Mare, J., Edkins, A.L. et al. 2013. Cytotoxicity of lapachol, β-lapachone and related synthetic 1, 4-naphthoquinones against oesophageal cancer cells. European Journal of Medicinal Chemistry. 6298-110.
  55. van der Watt, Pauline J, Stowell, C.L. & Leaner, V.D. 2013. The nuclear import receptor Kpnβ1 and its potential as an anticancer therapeutic target. Critical Reviews™ in Eukaryotic Gene Expression. 23(1)
  56. van Rooyen, B.A., Schafer, G., Leaner, V.D. & Parker, M.I. 2013. Tumour cells down-regulate CCN2 gene expression in co-cultured fibroblasts in a Smad7- and ERK-dependent manner. Cell Communication and Signaling : CCS. 1175-811X-11-75.
  57. Vergouwe, F., Boutall, A., Stupart, D., Algar, U., Govender, D., Van Der Linde, G., Mall, A., Ramesar, R. et al. 2013. Mismatch repair deficiency in colorectal cancer patients in a low-incidence area. South African Journal of Surgery. 51(1): 16-21.
  58. Wagner, R. & Fagan, J. 2013. Survey of otolaryngology services in Central America: need for a comprehensive intervention. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 149(5): 674-678.
  59. Wang, Y., Vogelsang, M., Schäfer, G., Matejcic, M. & Parker, M.I. 2013. MicroRNA Polymorphisms and Environmental Smoke Exposure as Risk Factors for Oesophageal Squamous Cell Carcinoma. PloS One. 8(10): e78520.
  60. Wansleben, S., Davis, E., Peres, J. & Prince, S. 2013. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. Cell Death & Disease. 4(10): e846.
  61. Warden, C., Stupart, D. & Goldberg, P. 2013. Stenting as first‐line management for all patients with nonperforating left‐sided obstructing colorectal cancer. Colorectal Disease. 15(7): e389-e395.
  62. Wei, W., Bracher-Manecke, J.C., Zhao, X., Davies, N.H., Zhou, L., Ai, R., Oliver, L., Vallette, F. et al. 2013. Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma. Cancer Biology & Therapy. 14(2): 164-174.